Population
Host cells infected with Hepatitis A virus (HAV)
Design
Preclinical
Authors
Loading...
Highlights potential HAV persistence mechanisms in animal models; leaves open clinical translation to human infection.
HAV establishes persistent infection by inhibiting dsRNA-induced antiviral responses and downregulating its own replication.
Brack et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: